四環生物(000518.SZ)簽訂景觀綠化合同 工程合同暫估價4081萬元
格隆匯12月13日丨四環生物(000518.SZ)公佈,公司的全資子公司江蘇晨薇生態園科技有限公司(“晨薇生態園”)於2019年12月13日與江西陽光文化旅遊發展有限公司(“江西陽光文化”)在江西德安簽訂了關於華夏陽光(德安)詩畫田園文化旅遊風景區的《景觀綠化合同》,工程合同暫估總價4081萬元。
公司及相關當事人於2019年9月19日收到中國證監會下發的《行政處罰及市場禁入事先告知書》([2019]135號),認定陸克平為公司實際控制人,與江西陽光文化為同一實際控制人,根據《深圳證券交易所股票上市規則》的規定,此次交易構成關聯交易。
目前,公司及相關當事人均申請了申辯及要求聽證,中國證監會尚未作出最終的處罰決定,有關實際控制人的判定以最終的《行政處罰決定書》為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.